Expression difference of FKBP51 in colorectal cancer and normal tissues and its relationship with clinicopathological features
10.3760/cma.j.issn.1008-1372.2017.03.012
- VernacularTitle:FKBP51在结直肠癌与正常组织中的表达差异及与临床病理特征的关系
- Author:
Zhixiu XIA
;
Changliang WANG
;
Yanshuo HAN
;
Chunsheng CHEN
;
Guohua ZHANG
;
Yong FENG
- Keywords:
Tacrolimus binding proteins/ME;
Colorectal neoplasms/ME
- From:
Journal of Chinese Physician
2017;19(3):362-366
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the difference of the expression level of FK506 Binding Protein 51 (FKBP51) in colorectal adenocarcinoma and normal colorectal tissues,and the correlation between FKBP51 expression level and clinicopathological characteristics,and to clarify whether FKBP51 is involved in the occurrence and development of colorectal cancer.Methods By immunohistochemical staining [streptavidin-peroxidase (SP) method] and Western blotting methods tested 31 cases of colorectal cancer tumor tissues and normal colorectal tissues far from tumor 5 cm,and explored the expression level difference of FKBP51.Combined with clinical data of patients,results were analyzed by statistical method x2 test of four case table data.Results The high expression rate of FKBP51 in tumor tissues was 74.19％ (23/31 cases),while the high expression rate of FKBP51 in normal tissue was 9.68％ (3/31 cases).The difference was significant.The expression level of FKBP51 in patients with colorectal carcinoma had no obvious correlation with gender (P =0.771),age (P =0.474),tumor location (P =0.213),degree of differentiation (P =0.318),lymph node metastasis (P =0.124),distant metastasis (P =0.318) and clinical stage (P =0.171);and the tumor size (P =0.049),depth of invasion related (P =0.031),the difference was statistically significant.Conclusions The expression of FKBP51 in colorectal cancer was strong,while weak expression in normal colorectal tissues.With the increase of tumor infiltration and deepening,the expression of FKBP51 became stronger,which indicated that FKBP51 participated in the genesis and development of colorectal cancer,and it might become a new target for individual therapy of colorectal cancer.
